Stay updated on Cabozantinib in Salivary Gland Cancer: Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Salivary Gland Cancer: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now includes a new revision note: v3.4.3. The previous revision note v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T18:45:34.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added. Notices about government funding and the prior Revision: v3.4.1 have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T09:27:01.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and NIH operations status has been added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:46:37.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The changes include showing the glossary (UI/help) and small wording/capitalization updates (Last Update Submitted that Met QC Criteria, No FEAR Act Data) along with a revision tag updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:11:47.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no new study information, endpoints, eligibility criteria, or contacts were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:35:05.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with Gelderland as a location. Removed the old Gelderland Locations label and the HHS Vulnerability Disclosure.
    Difference
    0.2%
    Check dated 2025-12-23T20:45:01.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Salivary Gland Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.